BFLY Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Growth And GuidanceManagement has delivered consistent double‑digit top‑line growth and reiterated full‑year guidance reflecting recurring software, enterprise and probe momentum. Durable revenue expansion improves scale economics, supports investment in AI/embedded rollouts, and underpins multi‑year demand across care settings.
Proprietary Ultrasound-on-chip And AI LeadershipButterfly’s ultrasound‑on‑chip platform plus FDA AI clearance and growing Compass AI pipeline create durable differentiation versus competitors. Proprietary silicon, validated AI and Embedded partnerships enable defensible product integration, recurring software monetization, and potential licensing or OEM expansion over years.
Conservative Leverage And Healthy Cash BalanceLow leverage and a sizable cash stockpile provide financial flexibility to fund commercialization, R&D and regulatory initiatives without immediate dilution. This strengthens runway for multi‑year product rollouts and enterprise sales cycles while reducing refinancing risk relative to early‑stage med‑tech peers.
Bears Say
Persistent Negative Operating Margins And Cash BurnDespite margin improvements, deep negative operating margins and ongoing negative cash flow indicate the business still requires sustained scale or structural cost reduction to reach profitability. Continued losses increase dependence on external capital if revenue or margin trajectories stall.
Embedded Revenue Concentration And Timing RiskRapid Embedded growth tied to one large partner creates concentration and timing risk for durable revenue forecasts. Multi‑year development cycles and confidential integrations mean revenue realization can be lumpy, delaying expected recurring software scale and pressuring near‑term margin improvement.
EU Regulatory Uncertainty From RoHS OutcomeShorter‑term RoHS reapproval increases regulatory friction and potential supply or market access constraints in the EU. Recurrent regulatory renewals add execution risk for durable European deployments and complicate long‑term planning and OEM/partner decisions in a key international market.
BFLY FAQ
What was Butterfly Network, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Butterfly Network, Inc.’s market cap?
Butterfly Network, Inc.’s market cap is $30.06B.
When is Butterfly Network, Inc.’s upcoming earnings report date?
Butterfly Network, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 4 days.
How were Butterfly Network, Inc.’s earnings last quarter?
Butterfly Network, Inc. released its earnings results on Apr 30, 2026. The company reported -$0.525 earnings per share for the quarter, beating the consensus estimate of -$0.858 by $0.333.
Is Butterfly Network, Inc. overvalued?
According to Wall Street analysts Butterfly Network, Inc.’s price is currently Undervalued.
Does Butterfly Network, Inc. pay dividends?
Butterfly Network, Inc. does not currently pay dividends.
What is Butterfly Network, Inc.’s EPS estimate?
Butterfly Network, Inc.’s EPS estimate is -0.61.
How many shares outstanding does Butterfly Network, Inc. have?
Butterfly Network, Inc. has 234,842,770 shares outstanding.
What happened to Butterfly Network, Inc.’s price movement after its last earnings report?
Butterfly Network, Inc. reported an EPS of -$0.525 in its last earnings report, beating expectations of -$0.858. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Butterfly Network, Inc.?
Currently, no hedge funds are holding shares in MX:BFLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Butterfly Network Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$100.68 (― Downside)
$100.68 (― Downside)
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
216.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.20%
Trailing 12-Months
Company Description
Butterfly Network, Inc.
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
BFLY Earnings Call
Q1 2026
0:00 / 0:00
BFLY Stock 12 Month Forecast
Average Price Target
$100.68